Related Experiment Videos

Clinical overview of vasculitic syndromes in the pediatric age

D Rigante1

  • 1Department of Pediatric Sciences, Università Cattolica Sacro Cuore, Rome, Italy. drigante@rm.unicatt.it

European Review for Medical and Pharmacological Sciences
|February 6, 2007
PubMed

Insights

Vasculitis involves blood vessel inflammation and necrosis. Accurate diagnosis is crucial for pediatric vasculitis, guiding treatment for conditions like Henoch-Schönlein purpura and Kawasaki disease.

Area of Science:

  • Pediatric rheumatology
  • Immunology
  • Vascular medicine

Background:

  • Vasculitic syndromes are diverse disorders characterized by inflammation and necrosis of blood vessels.
  • Clinical presentation varies based on vessel size, type, location, and inflammation severity.
  • Classification by vessel size is common in pediatric vasculitis, though prognoses and treatments differ significantly.

Purpose of the Study:

  • To highlight the heterogeneity of vasculitic syndromes in children.
  • To emphasize the importance of accurate diagnosis for effective treatment.
  • To discuss common pediatric vasculitides, including Kawasaki disease and Henoch-Schönlein purpura.

Main Methods:

  • Review of existing literature on pediatric vasculitis.
  • Classification of vasculitides based on affected vessel size.
  • Discussion of clinical presentations, diagnostic challenges, and therapeutic approaches.

Main Results:

  • Pediatric vasculitides present heterogeneously, influenced by vessel involvement and inflammation.
  • Henoch-Schönlein purpura, characterized by IgA immune complexes, is the most common pediatric vasculitis.
  • Kawasaki disease is a key medium-vessel vasculitis in this age group.

Conclusions:

  • Accurate diagnosis is paramount for tailoring treatment in pediatric vasculitis.
  • Therapeutic strategies are often empirical, supported by limited pediatric data.
  • Understanding disease heterogeneity is critical for managing pediatric vasculitis effectively.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...